2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$14.72+$0.14 (+0.96%)
Price as of Oct 02, 2026 4:36 PM EDT- $5.1BMarket Cap
- 584.51%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$14.72+$0.14 (+0.96%)
Earnings Score
Valuation | ERAS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | ERAS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.52% | ||
12-Month Momentum | 658.37% | ||
3-Month Risk Adjusted Momentum | -32.89% | ||
12-Month Risk Adjusted Momentum | 654.81% |
True Yield
Valuation | ERAS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ERAS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |